Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinoma.

Kelly PJ, Weiss SE, Sher DJ, Perez-Atayde AR, Dal Cin P, Choueiri TK.

J Clin Oncol. 2010 Sep 1;28(25):e433-5. doi: 10.1200/JCO.2009.26.8193. No abstract available.

PMID:
20547999
2.

Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: our experience and review of the literature.

Kusuda Y, Miyake H, Terakawa T, Furukawa J, Muramaki M, Fujisawa M.

Int J Urol. 2011 Apr;18(4):326-9. Review.

PMID:
25522450
3.

Editorial comment to "Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: our experience and review of the literature".

Hashimoto H.

Int J Urol. 2011 Apr;18(4):329-30. doi: 10.1111/j.1442-2042.2010.02720.x. No abstract available.

4.

Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.

Zeng H, Li X, Yao J, Zhu Y, Liu J, Yang Y, Qiang W.

Urol Int. 2009;83(4):482-5. doi: 10.1159/000251193.

PMID:
19996660
5.

Sunitinib-induced acute psychosis: case report.

Kunene V, Porfiri E.

Clin Genitourin Cancer. 2011 Sep;9(1):70-2. doi: 10.1016/j.clgc.2011.03.001. No abstract available.

PMID:
21729680
6.

Complete cerebral response with sunitinib for metastatic renal cell carcinoma.

Medioni J, Cojocarasu O, Belcaceres JL, Halimi P, Oudard S.

Ann Oncol. 2007 Jul;18(7):1282-3. No abstract available.

PMID:
17675397
7.

Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.

Edeline J, Laguerre B, Rolland Y, Patard JJ.

Ann Oncol. 2010 Jan;21(1):186-7. doi: 10.1093/annonc/mdp480. No abstract available.

PMID:
19875754
9.

Sunitinib in metastatic renal cell carcinoma patients with brain metastases.

Gore ME, Hariharan S, Porta C, Bracarda S, Hawkins R, Bjarnason GA, Oudard S, Lee SH, Carteni G, Nieto A, Yuan J, Szczylik C.

Cancer. 2011 Feb 1;117(3):501-9. doi: 10.1002/cncr.25452.

10.

Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.

Vickers MM, Heng DY, Hemmelgarn B, Eigl BJ.

Clin Genitourin Cancer. 2009 Oct;7(3):E104-6. doi: 10.3816/CGC.2009.n.035.

PMID:
19815480
11.

Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.

Szmit S, Nurzyński P, Szaluś N, Opolski G, Szczylik C.

Acta Oncol. 2009;48(6):921-5. doi: 10.1080/02841860902740907. No abstract available.

PMID:
19191048
12.

Reversible posterior leukoencephalopathy syndrome induced by sunitinib.

Martín G, Bellido L, Cruz JJ.

J Clin Oncol. 2007 Aug 10;25(23):3559. No abstract available.

PMID:
17687168
13.

Fatigue with sunitinib-induced hypothyroidism.

Senior K.

Lancet Oncol. 2007 Feb;8(2):101. No abstract available.

PMID:
17288042
14.

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, Reddy S, Dreicer R, Bukowski RM.

J Natl Cancer Inst. 2007 Jan 3;99(1):81-3.

PMID:
17202116
15.

Acute cardiac failure after sunitinib.

Machiels JP, Bletard N, Pirenne P, Jacquet L, Bonbled F, Duck L.

Ann Oncol. 2008 Mar;19(3):597-9. doi: 10.1093/annonc/mdn019. No abstract available.

PMID:
18272908
16.

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.

Rini BI, Choueiri TK, Elson P, Khasawneh MK, Cotta C, Unnithan J, Wood L, Mekhail T, Garcia J, Dreicer R, Bukowski RM.

Cancer. 2008 Sep 15;113(6):1309-14. doi: 10.1002/cncr.23711.

17.

Brain metastasis in renal cell cancer responding to sunitinib.

Koutras AK, Krikelis D, Alexandrou N, Starakis I, Kalofonos HP.

Anticancer Res. 2007 Nov-Dec;27(6C):4255-7.

18.

Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma.

Hill KL Jr, Lipson AC, Sheehan JM.

J Neurosurg. 2009 Sep;111(3):497-503. doi: 10.3171/2008.7.JNS08143.

PMID:
19199506
19.

Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma.

Mego M, Reckova M, Obertova J, Sycova-Mila Z, Brozmanova K, Mardiak J.

Ann Oncol. 2007 Nov;18(11):1906-7. No abstract available.

PMID:
17993633

Supplemental Content

Support Center